![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0247.jpg)
20.2 Notes to the consolidated financial statements for the year ended December 31, 2016
FINANCIAL INFORMATION CONCERNING ASSETS,
FINANCIAL POSITION AND FINANCIAL PERFORMANCE
20
NOTE 27.
OTHER LIABILITIES
CONTINUING OPERATIONS
Other operating liabilities
(in millions of euros)
December 31, 2016
December 31, 2015
Tax and social security liabilities, excluding corporate income tax
30
876
Financial instruments
22
299
Other operating liabilities
170
728
TOTAL
222
1,904
Financial instruments include the fair value of derivatives hedging market transactions and the fair value of the firm commitments hedged.
At December 31, 2016, other operating liabilities had a maturity of less than one year.
Other non-operating liabilities
Non-operating liabilities amounted to 3 million euros at December 31, 2016 (compared with 64 million euros at December 31, 2015).
OPERATIONS HELD FOR SALE
Other operating liabilities
(in millions of euros)
December 31, 2016
December 31, 2015
Operations held for sale in 2015
New NP
891
805
AREVA TA
100
146
Nuclear Measurements
-
51
Sub-total
991
1,002
Operations held for sale in 2016
NewCo
1,806
TOTAL (*)
2,798
1,002
* see note 3.
Other non-operating liabilities
(in millions of euros)
December 31, 2016
December 31, 2015
Operations held for sale in 2015
New NP
1
25
AREVA TA
1
1
Nuclear Measurements
-
0
Sub-total
2
26
Operations held for sale in 2016
NewCo
72
TOTAL (*)
74
26
* see note 3.
Other non-operating liabilities include mainly dividends payable to minority shareholders of certain subsidiaries.
2016 AREVA
REFERENCE DOCUMENT
245